Seneca Biopharma Inc. Shares Close the Day 10.4% Lower - Daily Wrap

The company saw its shares close the day 10.4% lower than yesterday, with trading volume higher than its 30 day average.

Mar 26, 2021 by Kwhen Finance Editors

Seneca Biopharma Inc. Shares Close the Day 10.4% Lower - Daily Wrap
Seneca Biopharma Inc. shares closed today 10.4% lower than it did at the end of yesterday. The stock is currently up 76.1% year-to-date, up 146.1% over the past 12 months, and down 99.3% over the past five years. Today, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.6%.

Trading Activity

  • Shares traded as high as $2.67 and as low as $1.52 this week.
  • Shares closed 4e+1% below its 52-week high and 2e+2% above its 52-week low.
  • Trading volume this week was 83.5% lower than the 10-day average and 60.2% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was between 30 and 70.
  • MACD, a trend-following momentum indicator, indicates an upward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Fundamentals & Catalysts

  • Over the past 12 months the company generated $-8,295,546 in earnings before interest and taxes from $13,520 in revenue. It currently holds $12 million in cash and $1 million in debt.
  • Its forward price-to-earnings (P/E) ratio of 0 is higher than its current P/E ratio of -1.65, implying that analysts are expecting a decrease in earnings.
  • The company's price/earnings-to-growth ratio (PEG Ratio), a widely used indicator of a stock's true value while also factoring in expected earnings growth, currently stands at -0.02. A fairly valued company should have a PEG ratio of 1.0. When a company's PEG exceeds 1.0, it's considered overvalued while a stock with a PEG of less than 1.0 is considered undervalued.
  • The company's debt-to-equity ratio, which measures the extent to which it finances its operations through debt, currently stands at 1.07 which means it currently has $1.07 of debt for every $1 of equity. Generally speaking, a debt to equity ratio below 1.0 is seen as relatively safe, while ratios of 2.0 or higher would be considered risky. Some industries are known for having much higher debt to equity ratios than others.
  • The company's price-to-book ratio, which measures the market's valuation of a company relative to its book value, currently stands at 1.64. This means that the stock is trading at a premium of 2 times relative to the company's book value which reflects the total value of a company's assets that shareholders of that company would receive if the company were to be liquidated.
  • The company's price-to-sales ratio, which shows how much the market values every dollar of the company's sales, currently stands at 1714.22.
  • The company's enterprise value-to-revenue multiple, which is often used to determine a company's valuation in the case of a potential acquisition, currently stands at 778.44.

P/E

-1.65

EBITDA

$-8,295,546

P/Book

1.64

Mkt Cap

$26M

P/Sales

1714.22

Revenue

$13,520

EPS (TTM)

-1.17

PEG Ratio

-0.02

EV/Revenue

778.44

Total Cash

$12M

Debt/Equity

1.07

Forward P/E

0.00

Current Debt

$1M

Gross Profit

$13,520

Dividend Date

-

Earnings Date

-

Profit Margin

-1027.04

Revenue/Share

0.00

Total Revenue

$13,520

Enterprise Val

$10M

Put/Call Ratio

0.00

Revenue/Employee

0.00

Market Comparative Performance

  • The company's share price lags the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
Seneca Biopharma Inc.-10.476.1146.1-38.2229.9
Dow Jones Industrial Average1.48.655.8-1.461.3
S&P 500 Index1.66.358.8-1.562.9
Health Care1.93.041.6-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 68.1%
  • The company's stock price performance over the past 12 months beats the peer average by 34.1%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
Seneca Biopharma Inc.SNCA-1.676.1146.1-38.2229.9
Peer AvgN/A045.3108.9-26.3202.9
Ocular Therapeutix IncOCUL0-18.0244.9-24.7324.4
OncoCyte Corp.OCX098.3130.1-25.9323.5
Oragenics Inc.OGEN0100.860.7-54.5163.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: